ES2080320T3 - Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae. - Google Patents

Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae.

Info

Publication number
ES2080320T3
ES2080320T3 ES91910767T ES91910767T ES2080320T3 ES 2080320 T3 ES2080320 T3 ES 2080320T3 ES 91910767 T ES91910767 T ES 91910767T ES 91910767 T ES91910767 T ES 91910767T ES 2080320 T3 ES2080320 T3 ES 2080320T3
Authority
ES
Spain
Prior art keywords
pct
immuno
mycobacterium chelonae
medication based
glycopeptidolipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91910767T
Other languages
English (en)
Inventor
Tsehay Neway
Charles Pilet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2080320T3 publication Critical patent/ES2080320T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICION FARMACEUTICA QUE CONTIENE COMO INGREDIENTE ACTIVO UNA FRACCION DE EXTRACCION AL MENOS PARCIALMENTE PURIFICADA DE GLICOPEPTIDOLIPIDOS POLARES DE MYCOBACTERIUM CHELONAE DE FORMULA (1). APLICACION EN PARTICULAR EN LA ESTIMULACION DE LA INMUNIDAD NO ESPECIFICA EN EL HOMBRE Y EN LOS ANIMALES.
ES91910767T 1990-06-06 1991-06-06 Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae. Expired - Lifetime ES2080320T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006997A FR2662942B1 (fr) 1990-06-06 1990-06-06 Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.

Publications (1)

Publication Number Publication Date
ES2080320T3 true ES2080320T3 (es) 1996-02-01

Family

ID=9397303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91910767T Expired - Lifetime ES2080320T3 (es) 1990-06-06 1991-06-06 Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae.

Country Status (12)

Country Link
US (1) US5336666A (es)
EP (1) EP0485577B1 (es)
JP (1) JP2709979B2 (es)
AT (1) ATE127021T1 (es)
AU (1) AU655425B2 (es)
CA (1) CA2063721C (es)
DE (1) DE69112573T2 (es)
DK (1) DK0485577T3 (es)
ES (1) ES2080320T3 (es)
FR (1) FR2662942B1 (es)
GR (1) GR3018244T3 (es)
WO (1) WO1991018617A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691797B2 (en) * 1993-01-29 1998-05-28 Vetrepharm, Inc. Immunotherapeutic composition
ATE210989T1 (de) * 1993-08-27 2002-01-15 Vetrepharm Inc Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
EP0971721A1 (en) * 1997-04-02 2000-01-19 Bioniche Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
HUP0202537A3 (en) 1999-08-24 2004-05-28 Teva Pharma A vaccine composition and method of using the same
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
TWI745278B (zh) 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物

Also Published As

Publication number Publication date
GR3018244T3 (en) 1996-02-29
FR2662942A1 (fr) 1991-12-13
EP0485577A1 (fr) 1992-05-20
DK0485577T3 (da) 1996-01-15
US5336666A (en) 1994-08-09
EP0485577B1 (fr) 1995-08-30
CA2063721A1 (fr) 1991-12-07
CA2063721C (fr) 1998-10-27
JP2709979B2 (ja) 1998-02-04
FR2662942B1 (fr) 1992-09-18
DE69112573T2 (de) 1996-04-25
JPH05500817A (ja) 1993-02-18
AU655425B2 (en) 1994-12-22
AU8090591A (en) 1991-12-31
ATE127021T1 (de) 1995-09-15
DE69112573D1 (de) 1995-10-05
WO1991018617A1 (fr) 1991-12-12

Similar Documents

Publication Publication Date Title
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
DE59401004D1 (de) Poly-1-n-alkenamine und diese enthaltende kraft- und schmierstoffzusammensetzungen
PT702560E (pt) Intensificacao imunologica com terapia intermitente de interleucina-2
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
GR3018244T3 (en) Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae.
DK345889D0 (da) Anvendelse af 5-ht-3-receptorantagonist
DE68918944D1 (de) Künstliche rezeptor-analoge.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
NO890046D0 (no) Disubstituerte pyridiner.
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
DK291390D0 (da) Terapeutiske anvendelser af 2',5'-oligoadenylatderivater
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
ATE183100T1 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
PT695303E (pt) Sais de piridinio e seu emprego no combate as bacterias helicobacter

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 485577

Country of ref document: ES